Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advancing glioblastoma research by establishing a whole brain slice model.

Frontiers in oncology·2026

Same author

Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneity.

Journal for immunotherapy of cancer·2026

Same author

End-of-life challenges in neuro-oncological patient care: A survey from the Junge Neuroonkologische Arbeitsgemeinschaft.

Neuro-oncology practice·2026

Same author

Artificial intelligence in neuro-oncology: Current advances and legal considerations in the European Union.

Neuro-oncology advances·2026

Same author

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.

Nature communications·2026

Same author

Phosphorylated mTOR immunohistochemistry-guided use of temsirolimus in recurrent IDH-wildtype glioblastoma: a real-world retrospective series.

Journal of cancer research and clinical oncology·2026

Search research articles

Related Experiment Video

Updated: Jul 27, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

BRMS1 in Gliomas-An Expression Analysis.

Jonas Feldheim^1,2,3, Almuth F Kessler¹, Julia J Feldheim^1,4

¹Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, Josef-Schneider-Str. 11, 97080 Würzburg, Germany.

|June 10, 2023

Summary

This summary is machine-generated.

The metastatic suppressor BRMS1 is decreased in gliomas, despite increased mRNA. This suggests BRMS1 may regulate glioma behavior, offering new research avenues for brain tumor treatment.

Keywords:

behavior glioblastoma mRNA metastasis protein suppressor

More Related Videos

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

Related Experiment Videos

Last Updated: Jul 27, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

Area of Science:

Neuro-oncology
Cancer Metastasis Research
Molecular Biology

Background:

The metastatic suppressor BRMS1 influences key steps in cancer metastasis.
BRMS1's role in gliomas is understudied due to their low metastatic potential.
BRMS1 interacts with known neuro-oncology targets like NFκB, VEGF, and MMPs.

Purpose of the Study:

To investigate BRMS1 expression and its clinical correlation in gliomas.
To explore BRMS1's potential as a regulator of glioma behavior.
To analyze BRMS1 mRNA and protein levels in astrocytomas and glioblastomas.

Main Methods:

Bioinformatic analysis of BRMS1 expression.
Analysis of BRMS1 mRNA and protein in 118 glioma specimens.
Correlation of BRMS1 expression with clinical course in astrocytomas (IDH mutant, CNS WHO grade 2/3) and glioblastomas (IDH wild-type, CNS WHO grade 4).

Main Results:

BRMS1 protein expression was significantly decreased in gliomas.
BRMS1 mRNA was found to be overexpressed in the studied gliomas.
Expression dysregulation was independent of patient characteristics or survival.

Conclusions:

BRMS1 expression is dysregulated in gliomas, with decreased protein and increased mRNA levels.
This suggests potential post-transcriptional regulation of BRMS1 in gliomas.
These findings provide a foundation for further research into BRMS1's role in glioma progression.